Pituitary-Tumor Endocrinopathies

• Consensus on acromegaly therapeutic outcomes: an update

  2025 Nature Reviews Endocrinology review Medicine Pituitary Gland Disorders and Treatments Open access cited by 1 patent

  86

  citations
• Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas

  2025 European Journal of Endocrinology article Medicine Pituitary Gland Disorders and Treatments Open access

  53

  citations
• Consensus on criteria for acromegaly diagnosis and remission

  2023 Pituitary article Medicine Pituitary Gland Disorders and Treatments Open access

  212

  citations
• Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project

  2023 Endocrine Connections article Biochemistry, Genetics and Molecular Biology Genomics and Rare Diseases Open access

  3

  citations
• Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

  2023 Nature Reviews Endocrinology review Medicine Pituitary Gland Disorders and Treatments Open access

  391

  citations
• Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

  2023 Pituitary article Medicine Pituitary Gland Disorders and Treatments Open access

  66

  citations
• MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly

  2023 The Journal of Clinical Endocrinology & Metabolism article Medicine Pituitary Gland Disorders and Treatments Open access

  24

  citations
• Validation of criteria for defining Pituitary Tumors Centers of Excellence (PTCOE)

  2023 Research Square preprint Medicine Pituitary Gland Disorders and Treatments Open access

  1

  citations
• Durable biochemical response and safety with oral octreotide capsules in acromegaly

  2022 European Journal of Endocrinology article Medicine Pituitary Gland Disorders and Treatments Open access

  19

  citations
• Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

  2021 The Lancet Diabetes & Endocrinology article Medicine Pituitary Gland Disorders and Treatments Open access

  56

  citations
• Consensus on diagnosis and management of Cushing's disease: a guideline update

  2021 The Lancet Diabetes & Endocrinology article Medicine Pituitary Gland Disorders and Treatments Open access

  930

  citations
• Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients

  2021 Pituitary article Medicine Pituitary Gland Disorders and Treatments Open access

  14

  citations
• Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

  2021 Pituitary article Medicine Pituitary Gland Disorders and Treatments Open access

  21

  citations
• Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

  2021 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access

  59

  citations
• Multidisciplinary management of acromegaly: A consensus

  2020 Reviews in Endocrine and Metabolic Disorders article Medicine Pituitary Gland Disorders and Treatments Open access

  346

  citations
• Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

  2020 The Journal of Clinical Endocrinology & Metabolism article Medicine Pituitary Gland Disorders and Treatments Open access cited by 1 patent

  103

  citations
• Endocrinology in the time of COVID-19: Management of pituitary tumours

  2020 European Journal of Endocrinology article Medicine Pituitary Gland Disorders and Treatments Open access

  40

  citations

17 results